Antibiotic-Resistant Organisms (AROs)
Annex A: Screening, Testing and Surveillance for Antibiotic-Resistant Organisms (AROs) In All Health Care Settings
Carbapenemase Producing Enterobacteriaceae (CPE)
Clostridioides difficile Infections (CDI)
Methicillin Resistant Staphylococcus aureus (MRSA)
Vancomycin resistant enterococci (VRE)
Fact Sheet - Clostridium difficile (C. difficile)
Fact Sheet - Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA)
Fact Sheet - Vancomycin-resistant Enterococci (VRE)
Candida auris
Measles
Mpox (formerly known as monkeypox)
Emerging and Re-Emerging Diseases
Appendix 1: Case Definitions and Disease Specific Information Disease: Candida auris
Emerging Diseases
Appendix 1: Case Definitions and Disease-Specific Information Disease: Gastroenteritis Outbreaks in Institutions and Public Hospitals
Recommendations for Outbreak Prevention and Control in Institutions and Congregate Living Settings
HNHB Summary of Recommendations for Outbreak Prevention and Control in Institutions and Congregate Living Settings
Gastrointestinal
Enteric Diseases and Food-Borne Diseases
Reportable Diseases of Public Health Significance
Infectious Diseases
Diseases and Conditions Index
Clinical Syndromes/Conditions with Required Level or Precautions
Appendix 1: Case Definitions and Disease Specific Information: Respiratory Infection Outbreaks in Institutions and Public Hospitals
COVID-19 Guidance for Public Health Units: Long-Term Care Homes, Retirement Homes, and Other Congregate Living Settings
COVID-19
Acute Respiratory Infections (ARI)
Influenza
Best Practices for the Prevention of Acute Respiratory Infection Transmission in All Health Care Settings
Respiratory Diseases
Coronavirus Disease 2019 (COVID-19)
Influenza (flu)
Cohorting in Respiratory Virus Outbreaks
Public Health Ontario Ontario Respiratory Virus Tool